Policy & Regulation

Flint Group has completed a major expansion of its Caronno resin facility in Italy, increasing annual output by 30% to strengthen supply for nitrocellulose-free inks targeting flexible packaging.

The US FDA has issued a new import alert impacting a broad range of products from a Guangdong-based company, according to the agency’s latest update on July 10, 2025.

The global biopharma sector navigated a challenging yet active first half of 2025, completing 32 mergers and acquisitions despite significant regulatory and geopolitical uncertainties.

On July 1, 2025, NHU (Zhejiang NHU Co., Ltd.) released its 2025 interim earnings forecast, expecting net profit attributable to shareholders to hit 33 billion to 37.5 billion yuan, marking a 50%-70% year-on-year growth.

On June 25, 2025, Novoloop, a chemical recycling innovator, announced the successful completion of a $21 million Series B funding round, led by Taranis, an investment firm focused on climate infrastructure and industrial decarbonization.

Driven by continued capital inflows into European markets, the euro-yuan exchange rate soared to its highest level since 2014.

Daiichi Sankyo and AstraZeneca announced that the FDA had approved Datopotamab Deruxtecan for its second indication, targeting locally advanced or metastatic EGFR-mutated non-small cell lung cancer (NSCLC) in adult patients who have previously undergone E

On June 20, 2025, Malaysia's Ministry of Health (MOH) released draft amendments to several food safety regulations, inviting public feedback until July 19, 2025.

Venetoclax, approved by the FDA in 2016 for treating 17p-deleted chronic lymphocytic leukemia (CLL), has been a blockbuster drug in hematologic cancers, earning over $2 billion in sales in 2024.

On June 16, India inaugurated the Second Policymakers' Forum at Sushma Swaraj Bhawan in New Delhi, bringing together representatives from 22 countries to advance global collaboration on drug standards and access to affordable medicines.

Australian startup Samsara Eco has signed a decade-long agreement with Lululemon to supply chemically recycled Nylon 66 and polyester fibers, furthering their shared commitment to circular fashion.

On June 12, 2025, the Swiss Federal Gazette published AS 2025 396, announcing amendments to food hygiene regulations.

Sun Pharma, India's largest drug manufacturer, announced on June 14, 2025, that the US Food and Drug Administration (USFDA) conducted an inspection at its Halol manufacturing facility in Gujarat from June 2-13, 2025.

India and China, the two largest global buyers of palm oil, are expected to aggressively increase imports in the short term, according to industry experts.

On June 10, 2025, the Brazilian Animal Protein Association (ABPA) reported a 296% increase in May egg exports, reaching 5,358 tons, with revenue surging 356.2% to $13.75 million.

Milliken & Company has officially launched its first chemical production facility in Asia, located in Singapore, to address the growing demand for advanced materials in the Asia-Pacific region.

In May 2025, the US FDA rejected 40 batches of food exports from China, citing reasons such as contamination, unsafe additives, and inaccurate labeling.

The company reported a consolidated annual revenue of ₹3379.7 crore (₹284.5 billion), reflecting a 4.5% decline year-on-year, while standalone revenue dropped 5.4% to ₹2942.1 crore (₹247.6 billion).

Since May 2025, the U.S. FDA has placed products from 28 Chinese companies under automatic detention due to various compliance issues.

In a significant development, the U.S. Food and Drug Administration (FDA) has placed a clinical hold on Rocket Pharmaceuticals’ mid-stage gene therapy trial following the death of a patient.